biote Statistics
Total Valuation
biote has a market cap or net worth of $474.58 million. The enterprise value is $509.64 million.
| Market Cap | 474.58M |
| Enterprise Value | 509.64M |
Important Dates
The next estimated earnings date is Thursday, August 8, 2024, after market close.
| Earnings Date | Aug 8, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
biote has 62.04 million shares outstanding. The number of shares has increased by 96.88% in one year.
| Shares Outstanding | 62.04M |
| Shares Change (YoY) | +96.88% |
| Shares Change (QoQ) | +34.66% |
| Owned by Insiders (%) | 29.77% |
| Owned by Institutions (%) | 52.81% |
| Float | 10.93M |
Valuation Ratios
The trailing PE ratio is 30.60 and the forward PE ratio is 17.37.
| PE Ratio | 30.60 |
| Forward PE | 17.37 |
| PS Ratio | 2.53 |
| Forward PS | 2.24 |
| PB Ratio | n/a |
| P/FCF Ratio | 26.55 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 21.61, with an EV/FCF ratio of 28.51.
| EV / Earnings | 63.30 |
| EV / Sales | 2.72 |
| EV / EBITDA | 21.61 |
| EV / EBIT | 25.65 |
| EV / FCF | 28.51 |
Financial Position
The company has a current ratio of 4.75
| Current Ratio | 4.75 |
| Quick Ratio | 3.61 |
| Debt / Equity | n/a |
| Debt / EBITDA | 4.83 |
| Debt / FCF | 6.37 |
| Interest Coverage | 2.73 |
Financial Efficiency
Return on equity (ROE) is -21.20% and return on invested capital (ROIC) is 25.44%.
| Return on Equity (ROE) | -21.20% |
| Return on Assets (ROA) | 5.30% |
| Return on Capital (ROIC) | 25.44% |
| Revenue Per Employee | $965,572 |
| Profits Per Employee | $41,500 |
| Employee Count | 194 |
| Asset Turnover | 1.24 |
| Inventory Turnover | 4.02 |
Taxes
In the past 12 months, biote has paid $4.54 million in taxes.
| Income Tax | 4.54M |
| Effective Tax Rate | 36.05% |
Stock Price Statistics
The stock price has increased by +13.00% in the last 52 weeks. The beta is 0.95, so biote's price volatility has been similar to the market average.
| Beta (5Y) | 0.95 |
| 52-Week Price Change | +13.00% |
| 50-Day Moving Average | 6.33 |
| 200-Day Moving Average | 5.46 |
| Relative Strength Index (RSI) | 69.35 |
| Average Volume (20 Days) | 364,223 |
Short Selling Information
The latest short interest is 1.11 million, so 1.79% of the outstanding shares have been sold short.
| Short Interest | 1.11M |
| Short Previous Month | 1.19M |
| Short % of Shares Out | 1.79% |
| Short % of Float | 10.17% |
| Short Ratio (days to cover) | 6.85 |
Income Statement
In the last 12 months, biote had revenue of $187.32 million and earned $8.05 million in profits. Earnings per share was $0.25.
| Revenue | 187.32M |
| Gross Profit | 129.95M |
| Operating Income | 31.20M |
| Pretax Income | 12.59M |
| Net Income | 8.05M |
| EBITDA | 23.58M |
| EBIT | 19.87M |
| Earnings Per Share (EPS) | $0.25 |
Balance Sheet
The company has $78.79 million in cash and $113.84 million in debt, giving a net cash position of -$35.06 million or -$0.57 per share.
| Cash & Cash Equivalents | 78.79M |
| Total Debt | 113.84M |
| Net Cash | -35.06M |
| Net Cash Per Share | -$0.57 |
| Equity (Book Value) | -35.40M |
| Book Value Per Share | -0.57 |
| Working Capital | 90.30M |
Cash Flow
In the last 12 months, operating cash flow was $21.26 million and capital expenditures -$3.39 million, giving a free cash flow of $17.88 million.
| Operating Cash Flow | 21.26M |
| Capital Expenditures | -3.39M |
| Free Cash Flow | 17.88M |
| FCF Per Share | $0.52 |
Margins
Gross margin is 69.38%, with operating and profit margins of 16.66% and 4.30%.
| Gross Margin | 69.38% |
| Operating Margin | 16.66% |
| Pretax Margin | 6.72% |
| Profit Margin | 4.30% |
| EBITDA Margin | 12.59% |
| EBIT Margin | 10.61% |
| FCF Margin | 9.54% |
Dividends & Yields
biote does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -96.88% |
| Shareholder Yield | -96.88% |
| Earnings Yield | 1.70% |
| FCF Yield | 3.77% |
Analyst Forecast
The average price target for biote is $8.11, which is 6.01% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $8.11 |
| Price Target Difference | 6.01% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | 17.09% |
| EPS Growth Forecast (5Y) | 104.24% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
biote has an Altman Z-Score of 3.37 and a Piotroski F-Score of 6.
| Altman Z-Score | 3.37 |
| Piotroski F-Score | 6 |